Meta-Analyses Do Not Establish Improved Mortality With Ivermectin Use in COVID-19

Am J Ther. 2021 Dec 7;29(1):e87-e94. doi: 10.1097/MJT.0000000000001461.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antiparasitic Agents / therapeutic use
  • COVID-19*
  • Humans
  • Ivermectin*
  • SARS-CoV-2
  • Treatment Outcome

Substances

  • Antiparasitic Agents
  • Ivermectin